[1] Chawla R., Navendu Goyal,Rajneesh Calton and Shweta Goyal , “Ischemia Modified Albumin : A novel Marker for Acute Coronary Syndromeâ€. Indian Journal of Clinical Biochemistry, 2006; 21(1) 77-82.
[2] Greenlund KJ, Giles WH, Keenan NL, et al. Heart disease and stroke mortality in the 20th century. In: Ward J, Warren C, eds. Silent victories: the history and practice of public health in twentieth century America; 2006.
[3] Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics.2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation, 2006;113:69-171.
[4]Prevalence of Heart Disease - United States. 2007;56 (06):113-118.
[5] Auxter, Sue (2003).Cardiac Ischemia Testing: A new era in chest pain evaluation. Clin. Lab. News, 29,1-3.
[6] Kontos, M.C. and Jesse, R.L. (2000). Evaluation of the emergency Dept. Chest pain patient. Am.J.Cardiol, 85,32B-39B.
[7] Gomez, M.A., Anderson, J.L., Karagounis L. A., Muhlestein, J. B. and Mooers, F. B. (1996). An emergency medicine based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense. Results of randomized study (ROMO). J. Am. Coll. Cardiol, 28: 25-33.
[8] Tsakiris AK, Marnelos PG, Nearchou NS, Papadakis JE, Karatzis EN, Skoufas PD. The influence of thrombolytic therapy on C-reactive protein in ST- segment elevation AMI. Hellenic J Cardiol, 2006;47:218-222.
[9] Mc Cord J. Oxygen-derived free radicals in post ischemic tissue injury. N Engl J Med, 1985; 312:159-163.
[10] Chan B, Dodsworth N, Woodrow J, Tucker A, Harris R. Site-specific N-terminal auto degradation of human serum albumin. Eur J Biochem, 1995;227:524-528.
[11] Roy D, Quiles J, Gaze DC, Collinson P, Kaski JC, Baxter GF. Role of reactive oxygen species on the formation of the novel diagnostic marker Ischemia modified albumin. Heart, 2006; 92:113-114.
[12] Bar-Or D, Lau E, Winkler JV. A novel assay for Cobalt-Albumin binding and its potential as a marker for myocardial ischemia- A preliminary report. J Emerg Med, 2000; 19:311-315.
[13] Eftihia Sbarouni, Panagiota Georgiadou, Dimitrios-TH. Kremastinos, Vasilios Voudris. Ischemia Modified Albumin: Is this Marker of Ischemia ready for prime time use? Hellenic J Cardiol, 2008; 49:260-266.
[14] Bar-Or D, Lau E, Winkler JV, Vanbenthuysen K, Harris L, Hetzel FW. Reduced Albumin Cobalt Binding with transient Myocardial Ischemia after elective percutaneous transluminal coronary angioplasty: A preliminary comparison to CK-MB, Myoglobin and Troponin I. Am Heart J, 2001; 141:985-991.
[15] Sinha NK, Gaze DC, Tippins JR, Collinson PO, kaski JC. IMA is a sensitive marker of Myocardial Ischemia after percutaneous coronary intervention. Circulation, 2003; 107:2403-2405.
[16] Bar Or, D.,Lau, E. Rao, N., Bampos, N.,Winkler, J. V. and Curtis, C. G. Reduction in the Cobalt Binding capacity of Human Albumin with Myocardial Ischemia. Ann. Emerg. Med, 1999;34:556
[17] Goldman L, Weinberg M, Weisberg M, et al. A computer derived protocol to aid in the diagnosis of ER patients with acute chest pain. N Engl J Med, 1982;307:588-96.
[18] Selker HP, Beshansky JR, Griffith JL, et al. Use of the acute cardiac ischemia time insensitive predictive instrument (ACI-TIPI) to assist with triage of patients with chest pain or other symptoms suggestive of acute cardiac ischemia. A multicentre, controlled clinical trial. Ann Intern Med, 1998; 129:845-55.
[19] Einstein AJ, Bodiam CA, Gill J. The relationships among performance measures in selection of diagnostic tests. Arch Pathol Lab Med, 1997;121:110-17.
[20] Quiles J, Roy D, Gaze D, et al. Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia. Am J Cardiol, 2003; 92: 322-324.
[21] Garrido IP, Roy D, Calvino R, et al. Comparison of ischemia modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without collaterals. Am J Cardiol, 2004; 93: 88-90.
[22] Sinha MK, Vazquez JM, Calvino R, Gaze DC, Collinson PO, Kaski JC. Effects of balloon occlusion during percutaneous coronary intervention on circulating ischemia modified albumin and transmyocardial lactate extraction. Heart, 2006; 92: 1852-1853.
[23] Apple FS, Quist HE, Otto AP, Mathews WE, Murakami MM. Release characteristics of cardiac biomarkers and ischemiamodified albumin as measured by the albumin cobalt-binding test after a marathon race. Clin Chem, 2002; 48: 1097-1100.